Connection

Eric Rovner to Urinary Incontinence

This is a "connection" page, showing publications Eric Rovner has written about Urinary Incontinence.
Connection Strength

5.587
  1. Is polypropylene mesh material fundamentally safe for use as a reconstructive material in vaginal surgery: ICI-RS 2019? Neurourol Urodyn. 2020 07; 39 Suppl 3:S132-S139.
    View in: PubMed
    Score: 0.709
  2. Implications of the FDA statement on transvaginal placement of mesh: the aftermath. Curr Urol Rep. 2014 Feb; 15(2):380.
    View in: PubMed
    Score: 0.467
  3. Urodynamic results and clinical outcomes with intradetrusor injections of onabotulinumtoxinA in a randomized, placebo-controlled dose-finding study in idiopathic overactive bladder. Neurourol Urodyn. 2011 Apr; 30(4):556-62.
    View in: PubMed
    Score: 0.381
  4. Effect of A 7-F transurethral catheter on abdominal leak point pressure measurement in men with post-prostatectomy incontinence. Urology. 2011 May; 77(5):1188-93.
    View in: PubMed
    Score: 0.379
  5. Tolterodine extended release is efficacious in continent and incontinent subjects with overactive bladder. Urology. 2008 Sep; 72(3):488-93.
    View in: PubMed
    Score: 0.318
  6. Long-term chronic complications from Stamey endoscopic bladder neck suspension: a case series. Int Urogynecol J Pelvic Floor Dysfunct. 2006 May; 17(3):290-4.
    View in: PubMed
    Score: 0.257
  7. Tolterodine for the treatment of overactive bladder: a review. Expert Opin Pharmacother. 2005 Apr; 6(4):653-66.
    View in: PubMed
    Score: 0.253
  8. Bone anchors for stress urinary incontinence in 2004: con. Urology. 2004 Nov; 64(5):851-4.
    View in: PubMed
    Score: 0.246
  9. Pharmacologic management of urinary incontinence in the female. Minerva Ginecol. 2004 Aug; 56(4):327-47.
    View in: PubMed
    Score: 0.242
  10. Trospium chloride in the management of overactive bladder. Drugs. 2004; 64(21):2433-46.
    View in: PubMed
    Score: 0.232
  11. Pharmacologic management of urinary incontinence in women. Urol Clin North Am. 2002 Aug; 29(3):537-50, viii.
    View in: PubMed
    Score: 0.210
  12. Does urinary urgency drive urinary frequency in overactive bladder? Low Urin Tract Symptoms. 2022 Jul; 14(4):242-247.
    View in: PubMed
    Score: 0.204
  13. Treatment of urinary incontinence. Curr Urol Rep. 2000 Oct; 1(3):235-44.
    View in: PubMed
    Score: 0.185
  14. Ventral hernia of the urinary bladder with mixed urinary incontinence: treatment with herniorrhaphy and allograft fascial sling. Urology. 2000 Jan; 55(1):145.
    View in: PubMed
    Score: 0.176
  15. Surgery for urinary incontinence in women: Report from the 6th international consultation on incontinence. Neurourol Urodyn. 2019 02; 38(2):825-837.
    View in: PubMed
    Score: 0.163
  16. Why anti-incontinence surgery succeeds or fails. Clin Obstet Gynecol. 1998 Sep; 41(3):719-34.
    View in: PubMed
    Score: 0.160
  17. Individualizing Urinary Incontinence Treatment: Research Needs Identified at NIDDK Workshop. J Urol. 2018 06; 199(6):1405-1407.
    View in: PubMed
    Score: 0.153
  18. New treatments for incontinence. Adv Chronic Kidney Dis. 2015 Jul; 22(4):279-88.
    View in: PubMed
    Score: 0.129
  19. Urethral diverticula: a review and an update. Neurourol Urodyn. 2007; 26(7):972-7.
    View in: PubMed
    Score: 0.071
  20. Tolterodine extended release improves overactive bladder symptoms in men with overactive bladder and nocturia. Urology. 2006 Aug; 68(2):328-32.
    View in: PubMed
    Score: 0.069
  21. Efficacy and tolerability of tolterodine extended-release in men with overactive bladder and urgency urinary incontinence. BJU Int. 2006 May; 97(5):1003-6.
    View in: PubMed
    Score: 0.068
  22. Nighttime dosing with tolterodine reduces overactive bladder-related nocturnal micturitions in patients with overactive bladder and nocturia. Urology. 2006 Apr; 67(4):731-6; discussion 736.
    View in: PubMed
    Score: 0.068
  23. Evaluation of lower urinary tract symptoms in females. Curr Opin Urol. 2003 Jul; 13(4):273-8.
    View in: PubMed
    Score: 0.056
  24. Definition and epidemiology of overactive bladder. Urology. 2002 Nov; 60(5 Suppl 1):7-12; discussion 12.
    View in: PubMed
    Score: 0.054
  25. Once-daily, extended-release formulations of antimuscarinic agents in the treatment of overactive bladder: a review. Eur Urol. 2002 Jan; 41(1):6-14.
    View in: PubMed
    Score: 0.051
  26. Evaluation and treatment of the overactive bladder. Rev Hosp Clin Fac Med Sao Paulo. 2002 Jan-Feb; 57(1):39-48.
    View in: PubMed
    Score: 0.051
  27. Injected periurethral collagen for postprostatectomy urinary incontinence: MR and CT appearance. Abdom Imaging. 2000 Nov-Dec; 25(6):658-62.
    View in: PubMed
    Score: 0.047
  28. Continence mechanism based on a modified ileocecal valve. Tech Urol. 2000 Sep; 6(3):167-71.
    View in: PubMed
    Score: 0.046
  29. Artificial urinary sphincter for post-prostatectomy incontinence: impact of prior collagen injection on cost and clinical outcome. J Urol. 2000 Jan; 163(1):87-90.
    View in: PubMed
    Score: 0.044
  30. The overactive bladder: an overview for primary care health providers. Int J Fertil Womens Med. 1999 Mar-Apr; 44(2):56-66.
    View in: PubMed
    Score: 0.042
  31. Posthysterectomy vaginal cuff fistula: diagnosis and management of an unusual cause of "incontinence". Urology. 1998 Jul; 52(1):61-4; discussion 64-5.
    View in: PubMed
    Score: 0.040
  32. The validation of patient-rated global assessments of treatment benefit, satisfaction, and willingness to continue--the BSW. Value Health. 2005 Nov-Dec; 8 Suppl 1:S25-34.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.